BIOERA SPA

F:B2A Germany Conglomerates
Market Cap
$515.22K
€501.93K EUR
Market Cap Rank
#37729 Global
#4927 in Germany
Share Price
€0.02
Change (1 day)
+0.00%
52-Week Range
€0.02 - €0.02
All Time High
€16.90
About

Bioera S.p.A. engages in the production and sale of organic and herbal products, natural cosmetics, and traditional food products in Italy. The company markets its products under the KI, Crudigno, and Fonte della Vita brand names; and distributes its products through outsourcers. The company was founded in 2004 and is headquartered in Milan, Italy.

BIOERA SPA (B2A) - Net Assets

Latest net assets as of : €- EUR

Based on the latest financial reports, BIOERA SPA (B2A) has net assets worth €- EUR as of .

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

BIOERA SPA - Net Assets Trend (None–None)

This chart illustrates how BIOERA SPA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for BIOERA SPA (None–None)

The table below shows the annual net assets of BIOERA SPA from None to None.

Year Net Assets Change
No yearly data available.

Equity Component Analysis

This analysis shows how different components contribute to BIOERA SPA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

BIOERA SPA Competitors by Market Cap

The table below lists competitors of BIOERA SPA ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in BIOERA SPA's equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares BIOERA SPA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently BIOERA SPA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Insufficient data available to analyze capital efficiency metrics.

Industry Comparison

This section compares BIOERA SPA's net assets metrics with peer companies in the Conglomerates industry.

Industry Context

  • Industry: Conglomerates
  • Average net assets among peers: $13,168,602,400
  • Average return on equity (ROE) among peers: 7.84%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
BIOERA SPA (B2A) €- N/A N/A $446.90K
Sumitomo Mitsui Construction Co. Ltd (72S) $30.07 Billion 13.97% 7.34x $518.52 Million
SGH Limited (9SG0) $4.12 Billion 11.28% 2.30x $4.92 Billion
BayWa Aktiengesellschaft (BYW) $1.18 Billion 8.31% 3.24x $478.06 Million
BayWa AktienGesellschaft Vink.N (BYW6) $1.44 Billion 2.74% 3.52x $93.47 Million
BayWa AG vNa (BYW6) $630.15 Million 3.74% 2.71x $94.29 Million
HPI AG (CEW3) $0.00 0.00% 0.00x $157.80
Ebara Jitsugyo Co.Ltd (EJI) $7.86 Billion 9.19% 1.66x $299.18 Million
Chargeurs SA (GET) $279.90 Million 7.90% 2.16x $77.49 Million
Kasumigaseki Capital Co.,Ltd. (H0A) $27.74 Billion 18.10% 1.80x $526.31 Million
H4W0 (H4W0) $58.37 Billion 3.22% 0.57x $15.80 Billion